HIGHLIGHTS
- What: Magnetic seed localisation demonstrates efficiency in TAD for NST-treated patients with positive nodes, facilitating accurate axillary pCR identification and safe omission of ALND in terms of survival and decreased associated morbidity in strong responders.
- Who: Munaser Alamoodi and colleagues from the London Breast Institute, The Princess Grace Hospital, Nottingham Place, London W U NY, UKDepartment of Surgery, King Abdulaziz University, Jeddah, Saudi Arabia have published the research work: Evaluating Magnetic Seed Localization in Targeted Axillary Dissection for Node-Positive Early Breast Cancer Patients Receiving Neoadjuvant Systemic Therapy: A Comprehensive Review and Pooled Analysis . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.